
Loading, please wait...

Loading, please wait...

Septic emboli secondary to infective endocarditis represent a significant clinical challenge. Specifically, infective mycotic aneurysm management becomes critical when these emboli lead to multiple vascular complications. This case highlights a 29-year-old man with MRSA endocarditis and intravenous drug use history. Initially, the patient presented with severe intracerebral and subarachnoid hemorrhage. Consequently, CT angiography revealed a left parieto-occipital hematoma causing a midline shift.
Surgeons promptly performed an emergency craniotomy for hematoma evacuation. During the procedure, they identified and clipped a ruptured distal middle cerebral artery (MCA) mycotic aneurysm. Furthermore, pathological analysis confirmed abscess formation within the aneurysm wall. Notably, a new distal MCA aneurysm developed within an abscess cavity despite aggressive antibiotic therapy. Therefore, clinicians had to adapt their strategy as the vascular pathology evolved rapidly.
Management took a complex turn when cerebral angiography later demonstrated a proximal M1 occlusion. Mechanical thrombectomy achieved partial reperfusion, consistent with Thrombolysis in Cerebral Infarction grade 2a. Moreover, the persistence of the abscess and new aneurysm necessitated Onyx embolization. Indeed, a hybrid operating room allowed the medical team to combine endovascular techniques with surgical abscess drainage effectively. This approach highlights the aggressive nature of septic emboli in younger patients.
Success in such cases depends on coordinated microsurgical and endovascular interventions. Clinicians must recognize that vascular pathology can evolve even under appropriate antimicrobial coverage. Additionally, early identification of large-vessel occlusion remains paramount. Combined surgical-endovascular strategies improve outcomes for patients facing concurrent mycotic aneurysms and abscesses. Consequently, hospital systems should prioritize multidisciplinary coordination to manage these rare and life-threatening manifestations.
Mycotic aneurysms often present as intracranial or subarachnoid hemorrhages. Patients may also show signs of systemic infection, focal neurological deficits, or sudden mental status changes due to septic emboli.
Recent studies suggest mechanical thrombectomy is a viable option for large-vessel occlusions caused by septic emboli. However, clinicians must balance the risk of vessel wall friability against the benefits of reperfusion.
A hybrid suite allows for simultaneous microsurgical clipping and endovascular embolization. This integration reduces transfer times and enables real-time imaging to guide complex surgical drainage and vascular repair.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This case explores the rare occurrence of M1 occlusion, multiple mycotic aneurysms, and cerebral abscesses caused by septic emboli in a 29-year-old patient....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today